202 related articles for article (PubMed ID: 31589480)
1. Prothymosin α promotes STAT3 acetylation to induce cystogenesis in Pkd1-deficient mice.
Chen YC; Su YC; Shieh GS; Su BH; Su WC; Huang PH; Jiang ST; Shiau AL; Wu CL
FASEB J; 2019 Nov; 33(11):13051-13061. PubMed ID: 31589480
[TBL] [Abstract][Full Text] [Related]
2. Transgenic overexpression of prothymosin alpha induces development of polycystic kidney disease.
Li KJ; Shiau AL; Chiou YY; Yo YT; Wu CL
Kidney Int; 2005 May; 67(5):1710-22. PubMed ID: 15840017
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression.
Formica C; Malas T; Balog J; Verburg L; 't Hoen PAC; Peters DJM
J Mol Med (Berl); 2019 Dec; 97(12):1643-1656. PubMed ID: 31773180
[TBL] [Abstract][Full Text] [Related]
4. Aquaporin-3 deficiency slows cyst enlargement in experimental mouse models of autosomal dominant polycystic kidney disease.
Wang W; Geng X; Lei L; Jia Y; Li Y; Zhou H; Verkman AS; Yang B
FASEB J; 2019 May; 33(5):6185-6196. PubMed ID: 30768374
[TBL] [Abstract][Full Text] [Related]
5. A cAMP and CREB-mediated feed-forward mechanism regulates GSK3β in polycystic kidney disease.
Kakade VR; Tao S; Rajagopal M; Zhou X; Li X; Yu AS; Calvet JP; Pandey P; Rao R
J Mol Cell Biol; 2016 Dec; 8(6):464-476. PubMed ID: 27190311
[TBL] [Abstract][Full Text] [Related]
6. Large deletion of Wdr19 in developing renal tubules disrupts primary ciliogenesis, leading to polycystic kidney disease in mice.
Yu SS; Wang E; Chiang CY; Cheng PH; Yeh YS; Wu YY; Chiou YY; Jiang ST
J Pathol; 2022 May; 257(1):5-16. PubMed ID: 35007346
[TBL] [Abstract][Full Text] [Related]
7. Functional TFEB activation characterizes multiple models of renal cystic disease and loss of polycystin-1.
Shillingford JM; Shayman JA
Am J Physiol Renal Physiol; 2023 Apr; 324(4):F404-F422. PubMed ID: 36794754
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of exogenous kidney-specific Ngal attenuates progressive cyst development and prolongs lifespan in a murine model of polycystic kidney disease.
Wang E; Chiou YY; Jeng WY; Lin HK; Lin HH; Chin HJ; Leo Wang CK; Yu SS; Tsai SC; Chiang CY; Cheng PH; Lin HJ; Jiang ST; Chiu ST; Hsieh-Li HM
Kidney Int; 2017 Feb; 91(2):412-422. PubMed ID: 28341240
[TBL] [Abstract][Full Text] [Related]
9. Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease.
Hassane S; Leonhard WN; van der Wal A; Hawinkels LJ; Lantinga-van Leeuwen IS; ten Dijke P; Breuning MH; de Heer E; Peters DJ
J Pathol; 2010 Sep; 222(1):21-31. PubMed ID: 20549648
[TBL] [Abstract][Full Text] [Related]
10. Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.
Li LX; Fan LX; Zhou JX; Grantham JJ; Calvet JP; Sage J; Li X
J Clin Invest; 2017 Jun; 127(7):2751-2764. PubMed ID: 28604386
[TBL] [Abstract][Full Text] [Related]
11. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ
Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977
[TBL] [Abstract][Full Text] [Related]
12. Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease.
Cruz NM; Song X; Czerniecki SM; Gulieva RE; Churchill AJ; Kim YK; Winston K; Tran LM; Diaz MA; Fu H; Finn LS; Pei Y; Himmelfarb J; Freedman BS
Nat Mater; 2017 Nov; 16(11):1112-1119. PubMed ID: 28967916
[TBL] [Abstract][Full Text] [Related]
13. Acute kidney injury induces hallmarks of polycystic kidney disease.
Kurbegovic A; Trudel M
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F740-F751. PubMed ID: 27488998
[TBL] [Abstract][Full Text] [Related]
14. miR-17~92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease.
Patel V; Williams D; Hajarnis S; Hunter R; Pontoglio M; Somlo S; Igarashi P
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10765-70. PubMed ID: 23759744
[TBL] [Abstract][Full Text] [Related]
15. Drug discovery for polycystic kidney disease.
Sun Y; Zhou H; Yang BX
Acta Pharmacol Sin; 2011 Jun; 32(6):805-16. PubMed ID: 21642949
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of prothymosin-α antagonizes TGFβ signalling to promote the development of emphysema.
Su BH; Tseng YL; Shieh GS; Chen YC; Wu P; Shiau AL; Wu CL
J Pathol; 2016 Feb; 238(3):412-22. PubMed ID: 26496995
[TBL] [Abstract][Full Text] [Related]
17. Mouse models of polycystic kidney disease induced by defects of ciliary proteins.
Ko JY; Park JH
BMB Rep; 2013 Feb; 46(2):73-9. PubMed ID: 23433108
[TBL] [Abstract][Full Text] [Related]
18. Raising serum uric acid with a uricase inhibitor worsens PKD in rat and mouse models.
Chaudhary A; He Z; Atwood DJ; Miyazaki M; Oto OA; Davidoff A; Edelstein CL
Am J Physiol Renal Physiol; 2024 Jun; 326(6):F1004-F1015. PubMed ID: 38634129
[TBL] [Abstract][Full Text] [Related]
19. Ectopic expression of Cux1 is associated with reduced p27 expression and increased apoptosis during late stage cyst progression upon inactivation of Pkd1 in collecting ducts.
Paul BM; Vassmer D; Taylor A; Magenheimer L; Carlton CG; Piontek KB; Germino GG; Vanden Heuvel GB
Dev Dyn; 2011 Jun; 240(6):1493-501. PubMed ID: 21465620
[TBL] [Abstract][Full Text] [Related]
20. Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain.
Kurbegovic A; Trudel M
Hum Mol Genet; 2013 Jun; 22(12):2361-75. PubMed ID: 23439951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
